This page uses content from Wikipedia and is licensed under CC BY-SA.

Methylenedioxycyclopropylmethylamphetamine

Methylenedioxycyclopropylmethylamphetamine
MDCPM.png
Names
IUPAC name
N-(cyclopropylmethyl)-1-(3a,7a-dihydro-1,3-benzodioxol-5-yl)propan-2-amine
Identifiers
3D model (JSmol)
ChemSpider
Properties
C14H21NO2
Molar mass 235.325 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

MDCPM, or 3,4-methylenedioxy-N-cyclopropylmethylamphetamine, is a lesser-known psychedelic drug. It is the N-cyclopropyl derivative of MDMA. MDCPM was first synthesized by Alexander Shulgin; it is also one of the compounds delineated in a patent by Horrom in 1972.[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 10 mg, and the duration unknown. MDCPM produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDCPM.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also

References

  1. ^ U.S. Patent 3,689,504
  2. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.

External links